8-KThe WireRoutine
Reg FD Disclosure
Filed Nov 3, 2023 · 2y ago · Accession 0001171843-23-006716
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Ticker
- BCRX
- CIK
- 882796
- Form type
- 8-K
- Filing date
- Nov 3, 2023
- Report date
- Nov 3, 2023
- Document
- f8k_110323.htm
- Size
- 226 KB